Latest News
ENA Respiratory nasal spray reduces viral replication in COVID-19 challenge study
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study
Uniseed’s Journey over past 20 years
A four-part article on Uniseed’s journey over the past 20 years. Each week in September, we will post a chapter covering the subsequent 5 years in Uniseed’s journey. Part 1 - 2000 - 2005 Part 2 - 2006 - 2010 Part 3 - 2011 - 2015 Part 4 - 2016 - 2020
Uniseed CEO Peter Devine talks with Global University Venturing’s Thierry Heles about Uniseed’s journey over the past 20 years
Uniseed CEO Peter Devine talks with Global University Venturing’s Thierry Heles about Uniseed’s journey over the past 20 years.
FDA Approves Xeglyze™ for the topical treatment of head lice infestation
Uniseed investee company Hatchtech, developing an innovative prescription head lice product, today announced that its commercialisation partner, Dr Reddy’s Laboratories, has achieved US Food and Drug Administration (FDA) approval of Xeglyze ….
Uniseed Investee Ferronova secures BioMedTech Horizons Grant
Nanotech company Ferronova secures BioMedTech Horizons Grant Uniseed investee Ferronova Pty Ltd has been awarded an $826,000 grant from the Australian Government’s BioMedTech Horizons (BTMH) program, operated by MTPConnect to further its nanoparticle development...
Uniseed and BioCurate sign early stage research commercialisation agreement
Uniseed and BioCurate sign early stage research commercialisation agreement Melbourne, 17 June, 2020 – BioCurate, an independently-operated joint venture between the University of Melbourne and Monash University, has entered into an agreement with leading Australian...
Uniseed invests in Nanotech company Ferronova
Nanotech company Ferronova secures $3.5m Series A funding led by Uniseed: Australian biotechnology company Ferronova Pty Ltd today closed a $3.5 million Series A financing round to fund clinical trials of its cancer tracing nanoparticle designed to find secondary cancer cells more accurately during cancer surgery.
Uniseed’s Investee Q-Sera and JHL Biotech, Inc announce a strategic collaboration
MEDIA Release Q-Sera Pty Ltd and JHL Biotech, Inc.
Improving access to Cardihab’s cardiac rehab during COVID-19 restrictions
Medibank Heart Health at Home app powered by Cardihab
Why our investment in PERKii® Probiotics is helping us stay healthy
PERKii® Probiotics’ new Apple and Ginger flavour is the latest probiotic drink out of the PERKii® lab, made with over 1 billion probiotics. “COVID-19 is having a devastating impact on people’s lives in Australia ….